All News

November 18, 2024

Chrysalis BioTherapeutics, Inc. Announces Collaboration with NIAID to Evaluate Chrysalin® for the Treatment of Cutaneous Radiation Injury

November 18, 2024

DigitalOwl Announces Strategic Collaboration with ExamOne to Improve Record Retrieval and Analysis

November 18, 2024

Contineum Therapeutics Expands Clinical Development of PIPE-791 With FDA Authorization of Its Investigational New Drug (IND) Application for Chronic Pain

November 15, 2024

Precision BioSciences Highlights Preclinical Data and Outlines Design of First-in-Human Clinical Trial for PBGENE-HBV for Treatment of Chronic Hepatitis B

November 15, 2024

Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases

November 15, 2024

Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite Instability–High or Mismatch Repair Deficient Metastatic Colorectal Cancer

November 14, 2024

U.S. Navy Awards Comtech $50 Million SLM-5650B Modem Contract

November 14, 2024

Sierra Space and DoE’s Oak Ridge National Laboratory Revolutionizing Thermal Protection for a New Generation of Commercial Space Transportation Vehicles

November 14, 2024

Reach Completes Phase II of Future Force Energy Campaign with U.S. Air Force, Demonstrating World’s First Wireless Power Relays

November 13, 2024

Asha Therapeutics Awarded Barnett Drug Development Grant by the ALS Association to Advance Novel Intra-Molecular Glue Inhibitor of SARM1 to Clinic and Announces Appointment of Disarm Therapeutics’ Founders to Company’s Scientific Advisory Board

November 13, 2024

GIOSTAR Announces FDA Clearance of the IND for Starting PHASE-2 Clinical Trial for Developing Specific Stem Cell Therapy for Type II Diabetes.

November 13, 2024

ScienceLogic® Announces Pursuit of FedRAMP® Moderate Authorization to Enable Digital Transformation and Innovation in the Public Sector

Business & Leadership